A systematic review and meta-analysis of five studies suggested that patients on GLP-1 receptor agonists were more likely to ...

CagriSema combines semaglutide, the active ingredient in Wegovy, with a molecule that mimics a pancreatic hormone.

It’s possible that GLP-1s may be useful for a range of substance use disorders, including opioid use disorder and nicotine ...

The GLP-1 receptor agonist exenatide failed to meet its primary outcome in a phase III trial of Parkinson's disease patients.

Novo Nordisk's GLP-1 receptor agonist semaglutide has been shown to ... pointing to yet another potential use for the versatile drug class. The small, 48-subject study – published in the journal ...

Even as millions of older adults clamor for drugs such as Ozempic and Wegovy, monthly use of the medications known as GLP-1 receptor agonists soared nearly 600% between 2020 and 2023 in people ...

As the body of research expands on the potential of glucagon-like peptide-1 receptor agonists to address various health ...

Women prescribed a GLP-1 receptor agonist up to 2 years before conception were less likely to develop hypertensive disorders of pregnancy, gestational diabetes, have a preterm birth or cesarean ...

The researchers found that both SGLT2 inhibitors and GLP-1 agonists were associated with a lower risk of major cardiovascular events, but the drug effects varied with the patients’ age.

Semaglutide, a medication widely used for diabetes and weight loss, may offer another unexpected benefit -- it could help ...

Companies such as Teladoc and Omada Health have embraced GLP-1s while dangling the prospect of lowered costs to their ...

If you've been around long enough, you will encounter some bumps in the road. This is true for The Hershey Company ( HSY -0.98%), whose history dates back to the 1890s. The company is among the most ...